{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T12:00:42Z","timestamp":1710763242585},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T00:00:00Z","timestamp":1400716800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s12032-014-0991-7","type":"journal-article","created":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T13:17:29Z","timestamp":1400678249000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-term quality of life outcomes in patients with locally advanced prostate cancer after intensity-modulated radiotherapy combined with androgen deprivation"],"prefix":"10.1007","volume":"31","author":[{"given":"Hua-chun","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-ping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-hua","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-chao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-guang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-shi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-fa","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui-shan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,22]]},"reference":[{"key":"991_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11\u201330.","journal-title":"CA Cancer J Clin"},{"key":"991_CR2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijrobp.2003.10.011","volume":"59","author":"JD Slater","year":"2004","unstructured":"Slater JD, Rossi CJ Jr, Yonemoto LT, et al. Proton therapy for prostate cancer: the initial Loma Linda University experience. Int J Radiat Oncol Biol Phys. 2004;59:348\u201352.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"991_CR3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1470-2045(11)70162-0","volume":"12","author":"E Johansson","year":"2011","unstructured":"Johansson E, Steineck G, Holmberg L, et al. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian prostate cancer group-4 randomised trial. Lancet Oncol. 2011;12:891\u20139.","journal-title":"Lancet Oncol"},{"key":"991_CR4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/PPO.0b013e3181570121","volume":"13","author":"DF Penson","year":"2007","unstructured":"Penson DF. Quality of life after therapy for localized prostate cancer. Cancer J. 2007;13:318\u201326.","journal-title":"Cancer J"},{"key":"991_CR5","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","volume":"358","author":"MG Sanda","year":"2008","unstructured":"Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358:1250\u201361.","journal-title":"N Engl J Med"},{"key":"991_CR6","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.2010.287","volume":"303","author":"JA Talcott","year":"2010","unstructured":"Talcott JA, Rossi C, Shipley WU, et al. Patient-reported longterm outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer. JAMA. 2010;303:1046\u201353.","journal-title":"JAMA"},{"key":"991_CR7","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ijrobp.2009.09.015","volume":"78","author":"PL Nguyen","year":"2010","unstructured":"Nguyen PL, Chen RC, Hoffman KE, et al. Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trial. Int J Radiat Oncol Biol Phys. 2010;78:1081\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"991_CR8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","volume":"56","author":"JT Wei","year":"2000","unstructured":"Wei JT, Dunn RL, Litwin MS, et al. Development and validation of the expanded prostate cancer index composite (epic) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56:899\u2013905.","journal-title":"Urology"},{"key":"991_CR9","doi-asserted-by":"crossref","unstructured":"Volz-Sidiropoulou E, Pinkawa M, Fischedick K, et al. Factor analysis of the Expanded Prostate Cancer Index Composite(EPIC) in a patient group after primary(external beam radiotherapy and permanent iodine-125 brachytherapy) and postoperative radiotherapy for prostate cancer. Curr Urol. 2008;2:122\u20139.","DOI":"10.1159\/000189652"},{"key":"991_CR10","doi-asserted-by":"crossref","unstructured":"Robert OD, Russell H, Craig C, et al. Overall survival benefit from postoperative radiation therapy for organ-confined, margin-positive prostate cancer. Int J Radiat Oncol Biol Phys 2011;79:719\u201323.","DOI":"10.1016\/j.ijrobp.2009.11.041"},{"key":"991_CR11","doi-asserted-by":"crossref","unstructured":"Luo HC, Cheng HH, Lin GS, et al. Intensity-modulated radiotherapy combined with endocrine therapy for intermediate and advanced prostate cancer: long-term outcome of Chinese patients. APJCP 2013;14:4711\u20135.","DOI":"10.7314\/APJCP.2013.14.8.4711"},{"key":"991_CR12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijrobp.2007.12.024","volume":"72","author":"M Ferrer","year":"2008","unstructured":"Ferrer M, Suarez JF, Guedea F, et al. Health-related quality of life 2\u00a0years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;72:421\u201332.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"991_CR13","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1200\/JCO.2009.25.3245","volume":"28","author":"Y Pardo","year":"2010","unstructured":"Pardo Y, Guedea F, Aguilo F, et al. Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment. J Clin Oncol. 2010;28:4687\u201396.","journal-title":"J Clin Oncol"},{"key":"991_CR14","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.urolonc.2011.12.020","volume":"31","author":"A Stensvold","year":"2013","unstructured":"Stensvold A, Dahl AA, Brennhovd B, et al. Bother problems in prostate cancer patients after curative treatment. Urol Oncol Semin Orig Investig. 2013;31:1067\u201378.","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"991_CR15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijrobp.2009.11.023","volume":"79","author":"AA Aizer","year":"2011","unstructured":"Aizer AA, Anderson NS, Oh SC, et al. The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2011;79:379\u201384.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"991_CR16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.radonc.2007.07.013","volume":"84","author":"C Cozzarini","year":"2007","unstructured":"Cozzarini C, Fiorino C, Di Muzio N, et al. Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer. Radiother Oncol. 2007;84:164\u201370.","journal-title":"Radiother Oncol"},{"key":"991_CR17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijrobp.2010.05.054","volume":"81","author":"M Pkinawa","year":"2011","unstructured":"Pkinawa M, Piroth MD, Holy R, et al. Quality of life after whole pelvic versus prostate-only external beam radiotherapy for prostate cancer: a matched-pair comparison. Int J Radiat Oncol Biol Phys. 2011;81:23\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"991_CR18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ijrobp.2011.07.005","volume":"83","author":"H Quon","year":"2012","unstructured":"Quon H, Cheung PC, Loblaw DA, et al. Quality of life after Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2012;83:617\u201323.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"991_CR19","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ijrobp.2004.12.083","volume":"62","author":"TM Muanza","year":"2005","unstructured":"Muanza TM, Albert PS, Smith S, et al. Comparing measures of acute bowel toxicity in patients with prostate cancer treated with external beam radiation therapy. Int J Radiat Oncol Biol Phys. 2005;62:1316\u201321.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"991_CR20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","volume":"16","author":"D Osoba","year":"1998","unstructured":"Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health related quality-of-life scores. J Clin Oncol. 1998;16:139\u201344.","journal-title":"J Clin Oncol"},{"key":"991_CR21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijrobp.2011.03.048","volume":"82","author":"JJ Coen","year":"2012","unstructured":"Coen JJ, Paly JJ, Niemierko A, et al. Long-term quality of life out after proton beam monotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012;82:201\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"991_CR22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ijrobp.2009.07.1748","volume":"78","author":"EA Wiegner","year":"2010","unstructured":"Wiegner EA, King CR. Sexual function after stereotactic body radiotherapy for prostate cancer: results of a prospective clinical trial. Int Radiat Oncol Biol Phys. 2010;78:442\u20138.","journal-title":"Int Radiat Oncol Biol Phys"},{"key":"991_CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijrobp.2009.01.070","volume":"76","author":"J Siglin","year":"2010","unstructured":"Siglin J, Kubicek GJ, Leiby B, et al. Time of decline in sexual function after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010;76:31\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"991_CR24","doi-asserted-by":"crossref","unstructured":"Schover LR, Fouladi RT, Warneke CL, et al. Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer 2002;95:1773e1785.","DOI":"10.1002\/cncr.10848"},{"key":"991_CR25","doi-asserted-by":"crossref","unstructured":"Wei JT, Dunn RL, Sandler HM, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 2002;20:557e566.","DOI":"10.1200\/JCO.20.2.557"},{"key":"991_CR26","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1200\/JCO.2009.25.3245","volume":"28","author":"Y Pardo","year":"2010","unstructured":"Pardo Y, Guedea F, Aguilo F, et al. Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment. J Clin Oncol. 2010;28:4678\u201396.","journal-title":"J Clin Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0991-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-014-0991-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0991-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T17:59:34Z","timestamp":1565459974000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-014-0991-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,22]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["991"],"URL":"https:\/\/doi.org\/10.1007\/s12032-014-0991-7","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,22]]},"article-number":"991"}}